Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not come back for the 2nd Shingrix dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 83-year-old male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Zostavax (received in 2017) and Shingrix (received 1st dose on 26-JUL-2018). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: did not come back for the 2nd Shingrix dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 26-SEP-2025 The pharmacy student called and informed that of their patient received in 2017 one dose of Zostavax, then on 26-JUL-2018 the same patient received one dose of Shingrix. Since then, the patient did not came back for the 2nd Shingrix dose. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination.